These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 4303641)

  • 21. [Microcirculatory therapy of multiple sclerosis].
    Schwarz D
    Minerva Med; 1970 Dec; 61(97):5543-61. PubMed ID: 4250225
    [No Abstract]   [Full Text] [Related]  

  • 22. [Effect of drug resistance of Mycobacterium tuberculosis on the therapeutic results of a drug to which sensitivity is retained(experimental data)].
    Belogurova VP; Ivanitskaia NN
    Antibiotiki; 1970 Feb; 15(2):154-7. PubMed ID: 4986204
    [No Abstract]   [Full Text] [Related]  

  • 23. [Clinical and epidemiological characteristics of patients with drug-resistant tuberculosis].
    Okulovskaia SS; Gurevich GL; Bogomazova AV
    Probl Tuberk; 1999; (6):6-8. PubMed ID: 10715945
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Drug resistance in tuberculosis.
    Ebrahim GJ
    J Trop Pediatr; 2007 Jun; 53(3):147-9. PubMed ID: 17526511
    [No Abstract]   [Full Text] [Related]  

  • 25. [Experimental study of secondary tuberculostatic preparations in view of the resistance of mycobacteria to the primary drugs].
    Uvarova OA; Zemskova ZS; Stukalova BIa; Afanas'eva IuP
    Farmakol Toksikol; 1967; 30(4):474-7. PubMed ID: 4877410
    [No Abstract]   [Full Text] [Related]  

  • 26. [Rifamicin in the studies of the Scuola Tisiologica in Naples].
    Nitti V
    Arch Tisiol Mal Appar Respir; 1968 Apr; 23(4):271-92. PubMed ID: 4981409
    [No Abstract]   [Full Text] [Related]  

  • 27. Short-course treatment regimens for patients with tuberculosis.
    Dutt AK; Stead WW
    Arch Intern Med; 1980 Jun; 140(6):827-9. PubMed ID: 6770770
    [No Abstract]   [Full Text] [Related]  

  • 28. [Resistance to antitubercular drugs in Chile].
    Valenzuela MT; Scheel G; Ponce J; Lepe R; Velasco M; Valenzuela P
    Rev Med Chil; 1984 Jan; 112(1):76-80. PubMed ID: 6429808
    [No Abstract]   [Full Text] [Related]  

  • 29. [Apropos of the use of vitamins in the treatment of chronic leukemia at its early stage. II].
    Cherntsvoa TA; Aksenova OV; Ivanova VD
    Probl Gematol Pereliv Krovi; 1966 May; 11(5):29-31. PubMed ID: 4230780
    [No Abstract]   [Full Text] [Related]  

  • 30. [Mode of action of "tuverculostatics". Consequences for the therapy].
    Krebs A
    Z Tuberk Erkr Thoraxorg; 1968; 128(1):208-17. PubMed ID: 4973006
    [No Abstract]   [Full Text] [Related]  

  • 31. [Effect of isoniazid and of a complex compound of cobalt with pyridoxine on rabbits infected with tuberculosis].
    Sodikov ES; Gapon'ko LA
    Farmakol Toksikol; 1972; 35(2):234-7. PubMed ID: 5017977
    [No Abstract]   [Full Text] [Related]  

  • 32. Drug resistance of Mycobacterium tuberculosis strains isolated from patients with pulmonary tuberculosis in Archangels, Russia.
    Toungoussova S; Caugant DA; Sandven P; Mariandyshev AO; Bjune G
    Int J Tuberc Lung Dis; 2002 May; 6(5):406-14. PubMed ID: 12019916
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The use of a combination of corticoids and vitamins with liver extract in adjuvant therapy of pulmonary tuberculosis].
    Mulargia A; Burnaccini P
    Minerva Med; 1969 May; 60(39):1902-8. PubMed ID: 5787473
    [No Abstract]   [Full Text] [Related]  

  • 34. [Correlation of lipid fractions, toxicity and virulence of M. tuberculosis isolated from patients treated with antibacterial preparations].
    Nemsadze MN
    Probl Tuberk; 1971; 49(11):66-9. PubMed ID: 5004859
    [No Abstract]   [Full Text] [Related]  

  • 35. Renal and miliary tuberculosis in an internationally adopted infant.
    Kay AW; McCarthy CA
    Pediatr Infect Dis J; 2009 Aug; 28(8):751-3. PubMed ID: 19633525
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Comparative results of treatment of pulmonary tuberculosis with the compounds of benzoyl-PAS-Ca-isoniazide and streptomycin-isoniazid].
    Favez G; Gonin JD; Gubéran E; de Kalbermatten JP; Vulliémoz P; Willa C
    Schweiz Med Wochenschr; 1969 Feb; 99(5):150-6. PubMed ID: 4974643
    [No Abstract]   [Full Text] [Related]  

  • 37. [Studies of the polychemoresistance of Mycobacterium tuberculosis].
    Curci G; De Franciscis V; Giuliano V
    Arch Monaldi; 1970; 25(2):99-114. PubMed ID: 4994908
    [No Abstract]   [Full Text] [Related]  

  • 38. Drug resistance in tuberculosis in Delhi: a 2 year profile (2001--2002).
    Negi SS; Gupta S; Lal S
    J Commun Dis; 2003 Jun; 35(2):74-81. PubMed ID: 15562952
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Experimental evidence for Mycobacterium tuberculosis persistence in M. tuberculosis-infected H37RV mice in the treatment with 3 first-line drugs (rifampicin, isoniazid, pyrazinamide)].
    Smirnova TG; Chernousova LN; Andreevskaia SN; Nikolaeva GM
    Probl Tuberk Bolezn Legk; 2004; (3):32-7. PubMed ID: 15338898
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analgesic and anti-inflammatory properties of vitamins.
    Hanck A; Weiser H
    Int J Vitam Nutr Res Suppl; 1985; 27():189-206. PubMed ID: 3926693
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.